Virupaksha Organics Ltd.: A Leading Producer of Fexofenadine HCl

Virupaksha Organics Ltd. has solidified its position as a key player in the global pharmaceutical industry, particularly in the production of Fexofenadine Hydrochloride (HCl), a widely used antihistamine for treating allergy symptoms. With cutting-edge manufacturing facilities in Telangana, India, Virupaksha adheres to the highest international standards of quality and compliance, ensuring the production of top-quality Fexofenadine HCl for both domestic and international markets.
Virupaksha’s facilities are certified by WHO-GMP, ISO 9001, and ISO 14001, which attests to the company’s commitment to maintaining rigorous quality control and environmental management. The company’s production capabilities and advanced R&D enable it to deliver cost-effective, high-purity APIs that meet the growing global demand for Fexofenadine HCl.
With its focus on innovation, sustainability, and customer satisfaction, Virupaksha Organics continues to be a trusted partner for pharmaceutical companies worldwide. Its strategic approach to producing APIs like Fexofenadine HCl positions the company as a leader in the antihistamine market, contributing to improved healthcare outcomes for millions of patients globally.
As the demand for allergy medications rises, Virupaksha Organics remains at the forefront of API production, demonstrating excellence in pharmaceutical manufacturing and reinforcing its status as a premier producer of Fexofenadine HCl.

Other Latest News
- Sensex, Nifty 50 end lower but outshine Asian peers; pharma shines April 3, 2025 11:40 am Mint Stock market today: Indian markets ended Thursday's session, April 3, lower, but outperformed most Asian peers, as the 26% duty, announced by the Donald Trump administration on Tuesday, on Indian exports, made it one of the least-tariffed Asian …
- Full list of UK exports tipped to be hit hardest by Trump tariffs – from cars to pharma April 3, 2025 11:34 am Daily Express Donald Trump's swingeing tariffs have been tipped to hit five UK exports the hardest, including cars and aircraft. The US President upended the global trade order on Wednesday as he announced sweeping levies on goods entering the United States from …
- Stock markets settle lower on selling in IT & Teck stocks, global sell-off as Trump hikes tariffs April 3, 2025 11:30 am The Hindu The U.S. has announced additional 27% import duties on India saying New Delhi imposes high tariffs on American goods, as Trump administration aims to reduce the trade deficit and boost manufacturing. File | Photo Credit: Reuters Benchmark indices Sensex …
- Stock markets slide over IT losses, global sell-off after Trump’s tariff hike April 3, 2025 11:19 am Orissa Post Mumbai: Benchmark indices Sensex and Nifty settled lower Thursday due to selling in IT and Teck shares and a global sell-off as US President Donald Trump unveiled reciprocal tariffs on 60 countries, including India. The 30-share BSE Sensex declined by 322. …
- UK pharma stocks avoid selloff April 3, 2025 10:53 am ShareCast At 1020 BST, AZN shares were up 1.4% at 11,383.49p, while GSK was 1.7% higher at 1,458p in a sharply lower London market, with the FTSE 100 down 1.3% at 8,501.02. Shore Capital analyst Dr Sean Conroy said that based on a clarifying Fact Sheet produced by …
- AMFI reshuffle: Mazagon Dock and Global Health among 18 stocks that may be upgraded in H2 CY25 April 3, 2025 10:31 am The Economic Times Mazagon Dock and Global Health are among 18 stocks that may soon be upgraded to the large-cap and mid-cap segments by the Association of Mutual Funds in India (AMFI) in its rejig for H2 CY25, according to predictions by Nuvama Institutional Equities. …
- Big relief for India! Trump spares pharma from harsh tariffs April 3, 2025 9:55 am The Economic Times In a big relief to India’s pharmaceutical industry, US President Donald Trump exempted pharmaceuticals, one of New Delhi's key export items to the US, from the new reciprocal tariffs rule on Thursday. "Some goods will not be subject to the …
- Pharma's exemption from reciprocal tariffs underscores generic medicines' critical role globally April 3, 2025 9:54 am The Economic Times The US administration has exempted pharmaceuticals from reciprocal tariffs, underscoring the critical role played by generic medicines globally, Indian Pharmaceutical Alliance (IPA) Secretary General Sudarshan Jain said on Thursday. President Donald Trump, …
- How a Ghanaian Lab Is Changing the Future of Global Cancer Research April 3, 2025 9:52 am Africa.com Several years after losing his father to liver cancer, Ghanaian immunologist Yaw Bediako launched Yemaachi Biotech to close a critical gap in African cancer research. The company, situated in Accra, is building Africa’s largest cancer genomics database—the …
- Indian drug exports get a tariff-free pass in the US April 3, 2025 9:22 am Business Today The United States has exempted Indian pharmaceutical exports from its newly announced tariffs, ensuring Indian drugmakers can continue supplying affordable medicines to the American market without additional cost burdens. The decision comes amid broader …
- Trump’s tariff gambit: Global shake-up, India’s balancing act, and the Modi template April 3, 2025 8:49 am News9 Live Opinion Analysis News As US President Donald Trump reshapes global trade with his unilateral tariff policies, the world scrambles to decode the implications. While economic fallout is inevitable, the political ramifications are just as significant. For …
- Gland Pharma receives USFDA nod for pain management injection Acetaminophen April 3, 2025 8:42 am Medical Dialogues Hyderabad: Gland Pharma Limited, a generic injectable-focused pharmaceutical company, has received approval from the United States Food and Drug Administration (USFDA) for Acetaminophen Injection, 10 mg/mL (500mg/50mL and 1000mg/100mL) Bags. …
- Pharma tariff exemption: Temporary relief, but higher tariffs may be imposed later, warns analyst April 3, 2025 8:32 am Financial Express US President Donald Trump has exempted pharmaceuticals from his reciprocal tariff plan announced on April 3. While he imposed a 26% tariff on other imports from India, this exemption has provided significant relief to pharmaceutical companies. However, …
- Experts Welcome US Reciprocal Tariff Exemption On Pharma, Call To Boost Domestic Manufacturing April 3, 2025 8:32 am MENAFN (MENAFN- IANS) New Delhi, April 3 (IANS) Industry experts on Thursday welcomed the exemption of Indian pharmaceutical exports from Trump's reciprocal tariffs while also stressing the need to strengthen domestic manufacturing.The experts cited the …
- Experts applaud US tariff exemption on pharma; stress need for strengthening domestic manufacturing April 3, 2025 8:05 am Daijiworld News Daijiworld Media Network – New Delhi New Delhi, Apr 3: Industry experts have welcomed the recent announcement by the United States to grant reciprocal tariff exemptions on Indian pharmaceutical exports, a move expected to significantly boost the sector’s …
- OneSource Pharma targets lion's share in generic GLP-1 market by FY27-28 as global demand surges April 3, 2025 7:57 am Business Today OneSource Specialty Pharma Limited, an Indian contract development and manufacturing organisation (CDMO), is gearing up to capture a 15-20% share in the generic GLP-1 market by FY27-28, betting on rising global demand for diabetes and weight management …
- Korean pharma and biotech to unveil innovative cancer research at AACR 2025 April 3, 2025 7:53 am Korea Biomedical Review A large number of Korean pharmaceutical and biotech companies are set to present their latest oncology research at the American Association for Cancer Research (AACR) Annual Meeting 2025, which will be held from April 25 to 30 in Chicago, Illinois. As one …
- Safeguarding jobs 'must be prioritised' in wake of US tariffs as risk of global trade war 'very real' April 3, 2025 7:51 am Irish Examiner US President Donald Trump's sweeping tariffs on EU imports will be a drag on manufacturing output and gross domestic product (GDP) growth in Ireland, with fears that punitive trade measures will also hurt the labour market and domestic demand. …
- Pharma companies’ stocks get a boost on U.S. tariff exemption April 3, 2025 7:17 am The Hindu Image used for representation purpose only. | Photo Credit: Getty Images/iStock Photo Indian pharma stocks were in focus on Thursday (April 3, 2025) early trading hours after the generic drugmakers got an exemption from U.S. tariff levy. Also read: …
- US tariffs: Indian pharma heaves a sigh of relief, for now; but not medical device makers April 3, 2025 7:06 am The Hindu Business Line Indian drugmakers are heaving a sigh of relief, for now, as United States President Donald Trump unveiled his “reciprocal tariff” plans. However, the relief does not extend to medical device makers. “Pharmaceuticals have been exempted from tariffs. The …
- 29pc tariff imposed on Pakistan as Trump’s sweeping import levies amp up global trade war April 3, 2025 7:05 am Dawn US President Donald Trump on Thursday imposed a 29 per cent tariff on goods the United States imports from Pakistan, along with higher duties on dozens of countries from rivals to allies and 10pc levies on most imports to his country, intensifying a global …
- Small-town Ireland nervous as Trump seeks to lure pharma investment to US April 3, 2025 7:05 am KFGO – North Dakota By Padraic Halpin and Maggie Fick CARRIGTWOHILL, Ireland (Reuters) – As U.S. President Donald Trump takes aim at the mostly American-owned pharmaceutical factories that dot the Irish countryside, the people of Carrigtwohill are getting nervous. A cluster …
- India’s pharma sector secures tariff exemption; IPA lauds boost for affordable medicines April 3, 2025 6:23 am Financial Express US President Donald Trump has exempted imports of pharmaceuticals, energy and certain minerals in his “reciprocal tariffs” on Thursday. Following this, shares of Indian pharmaceuticals companies with significant exposure to the United States, such as Gland …
- Trump tariff impact: Pharma stocks surge over 4% on tariff exemption April 3, 2025 6:23 am Financial Express It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical …
- Pharma tariff exemption to boost India-US trade ties: IPA’s Secretary General Sudarshan Jain April 3, 2025 6:20 am The News Mill The Indian Pharmaceutical Alliance (IPA) on Thursday welcomed the exclusion of pharmaceuticals from US tariffs, with Secretary General Sudarshan Jain emphasising the deepening of India-US trade ties under the Mission 500 initiative, aiming to double …